Share ownership InterCure Ltd.

INCR

IL0011063760

Healthcare Facilities & Services

Market Closed - TEL AVIV STOCK EXCHANGE Other stock markets 15:24:39 13/07/2026 BST			5-day change	1st Jan Change
300.20 ^ILa	-2.85%		-4.18%	-7.23%

06-22	InterCure Ltd. announced that it expects to receive ILS 21.711643 million in funding from Bennu Pharma Fund Ltd and other investors.	CI
06-15	InterCure Starts Review of US Medical Cannabis Opportunities; Completes Initial Closing of Botanico Acquisition	MT

Share class: InterCure Ltd.

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	59,228,556	36,026,889 ( 60.83 %)	0	60.83 %

Major shareholders: InterCure Ltd.

Name	Stocks	%	Valuation
Alexander Rabinovitch 25.01 %	14,812,562	25.01 %	16 M ILa
Yael Figel 6.951 %	4,116,947	6.951 %	5 M ILa
Yaron Jacobi 6.425 %	3,805,415	6.425 %	4 M ILa
IBI Mutual Funds Management (1978) Ltd. 0.8791 %	520,691	0.8791 %	575 311 ILa
Amos Cohen 0.7767 %	460,000	0.7767 %	508 254 ILa
Healthcare of Ontario Pension Plan Trust Fund 0.3588 %	212,500	0.3588 %	234 791 ILa
Ayalon Mutual Funds Ltd. 0.3058 %	181,116	0.3058 %	200 115 ILa
Psagot Mutual Funds Ltd. 0.2285 %	135,357	0.2285 %	149 556 ILa
Citadel Securities GP LLC 0.2261 %	133,919	0.2261 %	147 967 ILa
KSM Mutual Funds Ltd. 0.2159 %	127,898	0.2159 %	141 315 ILa
░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░

Breakdown by shareholder type

Individuals	39.17%
Institutional	2.04%
Others	0.66%
Unknown	58.13%

Based on 1000 largest holdings

Geographical origin of shareholders

Individuals	39.17%
Israel	1.69%
United States	0.65%
Canada	0.36%

Based on 1000 largest holdings

InterCure Ltd is an Israel-based company primarily enagged in cannabis industry. Thorugh its wholly owned subsidiary Canndoc the Company operates as licensed cannabis producer and one of the first to offer Good Manufacturing Practices (GMP) certified and pharmaceutical-grade medical cannabis products.

Employees

285

Sector

Healthcare Facilities & Services

More about the company